Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: Ethnic and genotypic influence

Journal of Medical Virology

Volumn 70, Issue 4, 2003, Pages 594-599

  Gad, Amal ^a,b   Tanaka, Eiji ^a   Matsumoto, Akihiro ^a   El Hamid Serwah, Abd ^b   Ali, Khalil ^b   Makledy, Fathy ^b   El Gohary, Ahmed ^b   Orii, Koji ^a   Ijima, Akihiro ^a   Rokuhara, Akinori ^a   Yoshizawa, Kaname ^a   Nooman, Zohair ^b   Kiyosawa, Kendo ^a,c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Suez Canal University Faculty of Medicine   (Egypt)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cryoglobulinemia; Ethnicity; Hepatitis C virus infection

Indexed keywords

ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EGYPT; ETHNIC GROUP; FEMALE; GENDER; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; SYMPTOM; VIRUS GENOME;

ASIAN CONTINENTAL ANCESTRY GROUP; CRYOGLOBULINEMIA; EGYPT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; JAPAN; MALE; MIDDLE AGED; RISK FACTORS;

HEPATITIS C VIRUS;

EID: 0037708295     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10435     Document Type: Article

References (28)

1. Agnello V, Chung RT, Kaplan LM. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495.
2. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddlestonet ALWF, et al. 1999. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938.
3. Angelico M, Renganathan E, Gundin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, Badr G, Rocchi G. 1997. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26:236-243.
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
5. Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P, Kaplanshi G, Charlotte F, Thibault V, Ghillani P, Piette JC, Caillat-Zucman S. 2001. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44: 2118-2124.
6. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. 1997. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341-1347.
7. Clough JD, Elrazak M, Calabrese LH, Valenzuela R, Braun WB, Williams GW. 1984. Weighted criteria for the diagnosis of systemic lupus erythematosus. Arch Intern Med 144:281-285.
8. Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, Santini GF, Chemello L, Alberti A. 1998. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinemia. J Viral Hepatol 5:179-185.
9. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap P-L, Sherlock S, McIntyre N. 1994. Hepatitis C virus genotypes: an investigation of type-specific difference in geographic origin and disease. Hepatology 19:13-18.
10. Frangeul L, Musset L, Cresta P, Cacoub P, Hurax JM, Lune F. 1996. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 25:427-432.
11. Gad A, Tanaka EJ, Orii K, Kafumi T, Serwah A, El-sherif A, Nooman Z, Kiyosawa K. 2000. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt. J Med Virol 60:177-181.
12. Gumber SC, Chopra S. 1995. Hepatitis C: a multifaceted disease. Ann Intern Med 123:615-620.
13. Horcajada JP, Garcia-Bengoechea M, Cilla G, Etxaniz P, Cuadrado E, Arenas JI. 1999. Mixed cryoglobulinemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 31:352-358.
14. Houghton M, Weiner A, Han J, Kuo G, Choo QL. 1991. Molecular biology of hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
15. Kamal S, Madwar M, Bianchi L, Tawil AEL, Fawzy R, Peter T, Rasenack JWF. 2000. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20:281-289.
16. Kawamura DM, Gill K, Beavers SE. 1992. Liver. In: Kawamura DM, editor. Diagnostic medical sonography: a guide to clinical practice. 1st ed. Vol. II: Philadelphia: JB Lippincott. p 126-128.
17. Leone N, Pellicano R, Ariata Maiocco I, Modena V, Marietti G, Rizzetto M, Ponzetto A. 2002. Mixed cryoglobulinemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol 66:200-203.
18. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. 1994. Viral and host factors that contribute to efficacy of Interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 39:1273-1280.
19. McCarty GA, Valencia DW, Fritzler MJ, editors. 1984. Antinuclear antibodies, contemporary techniques and clinical application to connective tissue disease. New York: Oxford University Press.
20. Nguyen QT, Ville ML, Ferriere F, Cohen P, Marullo DR, Coste T, Deny P, Guillevin L. 1998. Hepatitis C virus genotypes implicated in mixed cryoglobulinemia. J Med Virol 54:20-25.
21. Pawlotsky JM, Yahia MB, Andre C, Voisin MC, Intrator L, Thoraval FR, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux D. 1994. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19:841-848.
22. Richard AW. 1997. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1:4-16.
23. Silverman LM, Christenson RH, Grant GH. 1986. Aminoacids and proteins. In: Tietz NW, editor. Textbook of clinical chemistry. Philadelphia: WB Saunders. p 572-573.
24. Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakuma S. 1995. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 10: 1847-1852.
25. Tanaka EJ, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa S, Alter HJ. 2000. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of a genomic amplification of HCV RNA. Hepatology 32:388-393.
26. Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Man Thorpe R, Tabery H, Widell A, Lindgren S. 1999. Extrahepatic manifestations of chronic hepatitis C infection and interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients. J Intern Med 245:127-132.
27. Weiner SM, Berg T, Berthold H, Weber S, Peters T, Blum HE, Hopf U, Peter HH. 1998. A clinical and virological study of hepatitis C virusrelated cryoglobulinemia in Germany. J Hepatol 29:375-384.
28. Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Nevens F, Durez P, Treille S, Adler M, Desmet V, Fevery J, Yap SH. 1994. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol 44:266-271.